News and Press Releases

Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities

Protocol digitization extracts structured data elements from unstructured text Automates database study builds, reducing build timelines by up to 30% Deployed within 40 study builds across Emmes CRO’s portfolio of...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: August 14, 2024

401 N. Washington Street Suites 700 Rockville, MARYLAND 20850

Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

Investment in state-of-the-art imaging suite to accelerate data generation with physiologically-relevant in vitro models for deeper insights on drug effects in vivo Launch of advanced lung FMT assay provides extensive...

Category: Drug Discovery
Posted: August 8, 2024

Newcells Biotech, The Biophere, Drayman's Way, newcastle Helix, Newcastle-upon-Tyne, NE4 5BX

Deuterium Depletion Is the Key to Getting a Breakthrough in Cancer Therapy

Two review papers consolidate 30 years of research BUDAPEST, Hungary, July 25, 2024 / Biotech Newswire / -- HYD LLC for Cancer Research and Drug Development (HYD or the Company)...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: July 25, 2024

1118 Budapest, Villányi út 97., Hungary

Phase 2b Influenza Field Study Contract

hVIVO to enrol up to 1,000 healthy volunteers as part of a multicentre field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site Largest...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 2, 2024

40 Bank Street, Floor 24, London, E14 5NR

CatSci Announces Strategic Acquisition of Reach Separations to Offer End-To-End Separation Science Support from Discovery to Manufacture

25 June 2024 - Cardiff, UK - CatSci Ltd, an award-winning innovation partner for medicines development, announces the acquisition of Reach Separations, a specialist chromatography provider for the analysis and purification...

Category: BioManufacturing, Pharmaceutical
Posted: June 25, 2024

CBTC2 Capital Business Park Wentloog, Cardiff CF3 2PX

Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development

Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials June 24 2024, California, US, -Bio-Rad Laboratories, Inc. (NYSE: BIO...

Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: June 24, 2024

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Mage Biologics announces first subject dosed in a phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease

12 June 2024 -- Delaware, US -- Mage Biologics announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: June 19, 2024

Baslerstrasse 15 CH-4310 Rheinfelden Switzerland

Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

PPD clinical research business leads real-world data and technology panel, receives CRO Leadership Award 17 June 2024 -- California, US -- The PPD clinical research business of Thermo Fisher Scientific,...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 17, 2024

168 Third Avenue Waltham, MA 02451

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled...

Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: June 12, 2024

Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK

Altasciences Receives 2024 CRO Leadership Award for Capabilities

16 May 2024 -- Laval, Québec, Canada -- Altasciences announced today that it has been recognised for excellence in contract research with a 2024 CRO Leadership Award for Capabilities. This...

Category: BioManufacturing, Clinical Trials, Pharmaceutical
Posted: June 3, 2024

575 Armand-Frappier Blvd. Laval, QC H7V 4B3 Canada

TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team

3 June 2024 -- Hampshire, UK -- TMC Pharma Services, an established global product development and clinical research organisation (CRO) headquartered in Hampshire, UK, is pleased to announce the appointment...

Category: Clinical Trials, Pharmaceutical
Posted: June 3, 2024

Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK

New CRO Focused on Cannabis-based Drug Trials Launched

22 May 2024 -- Georgia, US -- Cannovation Clinical Research Partners, a pioneering Cannabis-Based clinical research organisation (CRO) for Drug and Product Development, is proudly announcing its official launch, marking...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: May 22, 2024

3300 Hamilton Mill Rd Ste 102 PMB 3024 Buford, GA 30519

PSI Partners With Medidata to Expand Data-Driven Feasibility Capabilities

30 April 2024 -- Zug, Switzerland -- PSI CRO, a leading full-service, global contract research organisation (CRO), today announced a partnership with Medidata, a Dassault Systèmes company and leading provider of clinical...

Category: Clinical Trials, Drug Discovery
Posted: May 2, 2024

Baarerstrasse 113a 6300 Zug Switzerland

TMC Pharma champions holistic approach to medical services in rare disease drug development

13 March 2024 – In a recent webinar, rare disease specialist and global clinical research organisation (CRO) TMC Pharma gathered esteemed speakers to share insights into the scope of medical...

Category: Drug Discovery, Pharmaceutical
Posted: March 13, 2024

Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK

Almost half of Brits think the Government is doing too little to encourage development of new medicines in the UK 

25 January -- London, UK -- Recent YouGov polling commissioned by clinical trials start-up Lindus Health has found that 47% of Brits want the Government to be doing more to...

Category: Pharmaceutical
Posted: January 25, 2024

unit 1, 120 Weston St, London SE1 4XE